Could stem cells slow ALS? new trial results are in
Disease control
Completed
This Phase 3 trial tested a stem cell treatment called Lenzumestrocel in 123 people with ALS. The treatment uses the patient's own bone marrow stem cells and is given alongside the standard drug Riluzole. The goal was to see if it could slow the disease and improve survival and f…
Phase: PHASE3 • Sponsor: Corestemchemon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC